Healy C - Search Results

1

Staging of melanoma, and the UK guidelines.

Russell-Jones R, Acland K, Calonje E, Doherty M, Healy C. Russell-Jones R, et al. Among authors: healy c. Br J Plast Surg. 2002 Jul;55(5):452-3. doi: 10.1054/bjps.2002.3863. Br J Plast Surg. 2002. PMID: 12372382 No abstract available.

2

Sentinel node biopsy for malignant melanoma. Staging procedures predict outcome and identify patients needing further treatment.

Russell-Jones R, Calonje E, Healy C, Doherty M, Butler P, Jones A, Whittaker S, Acland K. Russell-Jones R, et al. Among authors: healy c. BMJ. 2000 Nov 18;321(7271):1286-7. BMJ. 2000. PMID: 11082100 No abstract available.

3

Sentinel lymph node biopsy in malignant melanoma.

Healy C, Evans AV, Lister R, O'Doherty M, Calonje E, Acland K, Russell-Jones R. Healy C, et al. Br J Plast Surg. 2001 Apr;54(3):274-5. doi: 10.1054/bjps.2000.3531. Br J Plast Surg. 2001. PMID: 11254432 No abstract available.

4

Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma.

Acland KM, Healy C, Calonje E, O'Doherty M, Nunan T, Page C, Higgins E, Russell-Jones R. Acland KM, et al. Among authors: healy c. J Clin Oncol. 2001 May 15;19(10):2674-8. doi: 10.1200/JCO.2001.19.10.2674. J Clin Oncol. 2001. PMID: 11352959

5

Serum S100 concentrations are not useful in predicting micrometastatic disease in cutaneous malignant melanoma.

Acland K, Evans AV, Abraha H, Healy CM, Roblin P, Calonje E, Orchard G, Higgins E, Sherwood R, Russell-Jones R. Acland K, et al. Among authors: healy cm. Br J Dermatol. 2002 May;146(5):832-5. doi: 10.1046/j.1365-2133.2002.04691.x. Br J Dermatol. 2002. PMID: 12000380

6

High-dose interferon and the U.K. guidelines for cutaneous melanoma.

Russell-Jones R, Healy C, Calonje E, Doherty M, Acland K. Russell-Jones R, et al. Among authors: healy c. Br J Dermatol. 2002 Oct;147(4):832-4; author reply 834-5. doi: 10.1046/j.1365-2133.2002.505517.x. Br J Dermatol. 2002. PMID: 12366454 No abstract available.

7

Completion lymphadenectomy may not increase in-transit disease in malignant melanoma.

Russell-Jones R, Healy C, Powell AM, Acland K, O'Doherty M, Calonje E. Russell-Jones R, et al. Among authors: healy c. BMJ. 2004 Nov 27;329(7477):1288-9. doi: 10.1136/bmj.329.7477.1288-c. BMJ. 2004. PMID: 15564269 Free PMC article. No abstract available.

8

The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB).

Russell-Jones R, Powell AM, Acland K, Calonje E, O'Doherty M, Healy C. Russell-Jones R, et al. Among authors: healy c. Eur J Surg Oncol. 2005 Mar;31(2):210-1. doi: 10.1016/j.ejso.2004.10.009. Eur J Surg Oncol. 2005. PMID: 15698741 No abstract available.

9

Assessing response to chemotherapy in metastatic melanoma with FDG PET: Early experience.

Hofman MS, Constantinidou A, Acland K, Healy C, Harries M, O'Doherty M; Melanoma Group. Hofman MS, et al. Among authors: healy c. Nucl Med Commun. 2007 Dec;28(12):902-6. doi: 10.1097/MNM.0b013e3282f1b97b. Nucl Med Commun. 2007. PMID: 18090215 Clinical Trial.

10

Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit.

Constantinidou A, Hofman M, O'Doherty M, Acland KM, Healy C, Harries M. Constantinidou A, et al. Among authors: healy c. Melanoma Res. 2008 Feb;18(1):56-60. doi: 10.1097/CMR.0b013e3282f62404. Melanoma Res. 2008. PMID: 18227709

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

620 results

Search Page

Filters